MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?

Elterman et al. in their recent mini review introduced the concept of first-line interventional treatment (FIT). The authors define FIT as a novel paradigm bridging the gap between medications and surgery. More specifically, FIT ideally should provide effective, minimally invasive symptom relief with rapid recovery, minimal side effects, and preserved treatment adaptability. Moreover, it should integrate outpatient easibility, durability, and patientcentered outcomes, addressing both urologist and patient expectations. Finally, the authors clarify that the available minimally invasive surgical treatments (MISTs) do not meet the required criteria and therefore efforts should be made to develop the ideal FIT soon.